» Articles » PMID: 36612042

A Race-Specific, DNA Methylation Analysis of Aging in Normal Rectum: Implications for the Biology of Aging and Its Relationship to Rectal Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jan 8
PMID 36612042
Authors
Affiliations
Soon will be listed here.
Abstract

Approximately 90% of colorectal cancer (CRC) develop over the age of 50, highlighting the important role of aging in CRC risk. African Americans (AAs) shoulder a greater CRC burden than European Americans (EA) and are more likely to develop CRC at a younger age. The effects of aging in AA and EA normal rectal tissue have yet to be defined. Here, we performed epigenome-wide DNA methylation analysis in the first, large-scale biracial cohort of normal rectum ( = 140 samples). We identified increased epigenetic age acceleration in EA than AA rectum ( = 3.91 × 10) using linear regression. We also identified differentially methylated regions (DMRs) associated with chronological aging in AA and EA, separately using DMRcate. Next, a consensus set of regions associated with cancer was identified through DMR analysis of two rectal cancer cohorts. The vast majority of AA DMRs were present in our analysis of aging in rectum of EA subjects, though rates of epigenetic drift were significantly greater in AA ( = 1.94 × 10). However, 3.66-fold more DMRs were associated with aging in rectum of EA subjects, many of which were also associated with rectal cancer. Our findings reveal a novel relationship between race, age, DNA methylation and rectal cancer risk that warrants further investigation.

Citing Articles

Recent racial/ethnic disparities in cancer-specific mortality among patients diagnosed with rectal cancer.

Li L, Xu Z, Chen G, Zhang L, Lu Z, Chen C Transl Gastroenterol Hepatol. 2024; 9:37.

PMID: 39091646 PMC: 11292083. DOI: 10.21037/tgh-24-1.


Novel DNA methylation-based epigenetic signatures in colorectal cancer from peripheral blood leukocytes.

Jung S, Yu H, Tan X, Pellegrini M Am J Cancer Res. 2024; 14(5):2253-2271.

PMID: 38859857 PMC: 11162685. DOI: 10.62347/MXWJ1398.


Open access-enabled evaluation of epigenetic age acceleration in colorectal cancer and development of a classifier with diagnostic potential.

Widayati T, Schneider J, Panteleeva K, Chernysheva E, Hrbkova N, Beck S Front Genet. 2023; 14:1258648.

PMID: 37953923 PMC: 10634722. DOI: 10.3389/fgene.2023.1258648.


Assessment of Colorectal Cancer Risk Factors through the Application of Network-Based Approaches in a Racially Diverse Cohort of Colon Organoid Stem Cells.

Devall M, Eaton S, Yoshida C, Powell S, Casey G, Li L Cancers (Basel). 2023; 15(14).

PMID: 37509213 PMC: 10377524. DOI: 10.3390/cancers15143550.


A Multi-Omics Overview of Colorectal Cancer to Address Mechanisms of Disease, Metastasis, Patient Disparities and Outcomes.

Yang G, Yu X, Weisenberger D, Lu T, Liang G Cancers (Basel). 2023; 15(11).

PMID: 37296894 PMC: 10251979. DOI: 10.3390/cancers15112934.

References
1.
Haider S, Waggott D, Lalonde E, Fung C, Liu F, Boutros P . A bedr way of genomic interval processing. Source Code Biol Med. 2016; 11:14. PMC: 5157088. DOI: 10.1186/s13029-016-0059-5. View

2.
Aryee M, Jaffe A, Corrada-Bravo H, Ladd-Acosta C, Feinberg A, Hansen K . Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014; 30(10):1363-9. PMC: 4016708. DOI: 10.1093/bioinformatics/btu049. View

3.
Wolf A, Fontham E, Church T, Flowers C, Guerra C, LaMonte S . Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018; 68(4):250-281. DOI: 10.3322/caac.21457. View

4.
Devall M, Sun X, Yuan F, Cooper G, Willis J, Weisenberger D . Racial Disparities in Epigenetic Aging of the Right vs Left Colon. J Natl Cancer Inst. 2020; 113(12):1779-1782. PMC: 8634501. DOI: 10.1093/jnci/djaa206. View

5.
Mannick J, Teo G, Bernardo P, Quinn D, Russell K, Klickstein L . Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials. Lancet Healthy Longev. 2021; 2(5):e250-e262. PMC: 8102040. DOI: 10.1016/S2666-7568(21)00062-3. View